Postmenopausal women may have a powerful new edge in the battle against weight gain. A Mayo Clinic study found that those using menopausal hormone therapy while taking the obesity drug tirzepatide lost about 35% more weight than those on the drug alone. The findings hint at a surprising synergy betw een hormones and cutting-edge weight-loss medications, potentially opening the door to more effective, personalized treatments for millions of women facing increased cardiometabolic risks after menopause. ...read more read less